Need to know:

Type 1 diabetes is an autoimmune condition characterised by the destruction of the pancreatic beta cells, resulting in the inability to produce insulin. Exogenous insulin therapy is required for life.

The goal of therapy is to keep blood glucose levels as close to a normal, non-diabetic range as possible to prevent acute hypoglycaemia and the long-term complications of hyperglycaemia.

Patients with type 1 diabetes must self-titrate insulin doses multiple times a day, taking into account the carbohydrate to be eaten and the current blood glucose level. This is no simple task and is further complicated by up to 42 factors that can impact blood glucose levels — for example, sleep, stress and illness.¹